Cover Image

Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy

AbstractContext The mechanisms of Traditional Chinese Medicine (TCM) Guizhi-Gancao Decoction (GGD) remain unknown.Objective This study explores the mechanisms of GGD against cardiac hypertrophy.Materials and methods Network pharmacology analysis was carried out to identify the potential targets of G...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kaijing Yang (Author), Xiaoli Shan (Author), Yang Songru (Author), Mengwei Fu (Author), Pei Zhao (Author), Wei Guo (Author), Ming Xu (Author), Huihua Chen (Author), Rong Lu (Author), Chen Zhang (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway
by: Dongdong Qian, et al.
Published: (2022)

Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro
by: Dandan Feng, et al.
Published: (2018)

Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model
by: Jiye Chen, et al.
Published: (2021)

A network pharmacology study on the main active constituents and key pharmacological pathways of Shaoyao Gancao decoction on Osteoarthritis
by: Qiuyue LI, et al.
Published: (2021)

Effects of Huangqi Gancao Decoction on intestinal immunity and microbiota in immunocompromised mice models
by: Hai Zhou, et al.
Published: (2024)

Huangqi Guizhi Wuwu Decoction Improves Arthritis and Pathological Damage of Heart and Lung in TNF-Tg Mice
by: Yi Wang, et al.
Published: (2022)

Stachytine Hydrochloride Improves Cardiac Function in Mice with ISO-Induced Heart Failure by Inhibiting the α-1,6-Fucosylation on N-Glycosylation of β1AR
by: Panwei Hu, et al.
Published: (2022)

Gancao Nurish-Yin Decoction medicated serum inhibits growth and migration of ovarian cancer cells: Network pharmacology-based analysis and biological validation
by: Rongbin Pan, et al.
Published: (2022)

Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
by: Li Ru, et al.
Published: (2023)

The mechanisms of Huangqi Guizhi Wuwu decoction in treating ischaemic stroke based on network pharmacology and experiment verification
by: Weiguo Liao, et al.
Published: (2023)

Integrated network pharmacology and serum metabolomics approach deciphers the anti-colon cancer mechanisms of Huangqi Guizhi Wuwu Decoction
by: Boyu Pan, et al.
Published: (2022)

Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites
by: Luo YT, et al.
Published: (2022)

Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis
by: Zhengwei Zhang, et al.
Published: (2023)

Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway
by: Lihua Cui, et al.
Published: (2021)

SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300
by: Peiye Shen, et al.
Published: (2016)

Network pharmacology and molecular docking to elucidate the mechanism of pulsatilla decoction in the treatment of colon cancer
by: Huan Liu, et al.
Published: (2022)

Gancao Nourishing-Yin decoction combined with methotrexate in treatment of aging CIA mice: a study based on DIA proteomic analysis
by: Yong Chen, et al.
Published: (2023)

Shaoyao Gancao Decoction Ameliorates Paclitaxel-Induced Peripheral Neuropathy via Suppressing TRPV1 and TLR4 Signaling Expression in Rats
by: Chen Y, et al.
Published: (2022)

Modified Guizhi Shaoyao Zhimu Decoction in the treatment of gout: A systematic review and meta-analysis
by: Hao Liu, et al.
Published: (2022)

Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation
by: Congping Su, et al.
Published: (2019)

Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis
by: Mingming Li, et al.
Published: (2022)

Zhiqiao Gancao Decoction Ameliorates Hyperalgesia in Lumbar Disc Herniation via the CCL2/CCR2 Signaling Pathway
by: Huang Z, et al.
Published: (2023)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
by: Jingwei Li, et al.
Published: (2022)

Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro
by: Yuqin Zhang, et al.
Published: (2023)

Efficacy and tolerability of Guizhi-Shaoyao-Zhimu decoction in gout patients: a systematic review and Meta-analysis
by: Qing Zhang, et al.
Published: (2020)

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions
by: Ya Liu, et al.
Published: (2021)

Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology
by: Sutong Wang, et al.
Published: (2023)

Effect of Different Ratios of Yinchen and Gancao Decoction on ANIT-Treated Cholestatic Liver Injury in Mice and Its Potential Underlying Mechanism
by: Huizong Su, et al.
Published: (2021)

Circular RNAs in the regulation of cardiac hypertrophy
by: Siyi Wu, et al.
Published: (2022)

The Effect of Shaoyao Gancao Decoction on Sphincter of Oddi Dysfunction in Hypercholesterolemic Rabbits via Protecting the Enteric Nervous System–Interstitial Cells of Cajal–Smooth Muscle Cells Network
by: Zhu GY, et al.
Published: (2021)

Dangshen Erling Decoction Ameliorates Myocardial Hypertrophy via Inhibiting Myocardial Inflammation
by: Yigang Zhong, et al.
Published: (2022)

Pharmacokinetic incompatibility of the Huanglian-Gancao herb pair
by: Ji-Quan Zhang, et al.
Published: (2020)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
by: Yan Chen, et al.
Published: (2022)

Herbal formula Huangqi Guizhi Wuwu decoction attenuates paclitaxel-related neurotoxicity via inhibition of inflammation and oxidative stress
by: Zhangming Lv, et al.
Published: (2021)

Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
by: Xiao Liu, et al.
Published: (2019)

Shaoyao-Gancao Decoction Promoted Microglia M2 Polarization via the IL-13-Mediated JAK2/STAT6 Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury
by: Juanjuan Lu, et al.
Published: (2022)

Shaoyao Gancao decoction alleviates paclitaxel-induced cognitive impairment by activating PTEN/PI3K/AKT pathway to inhibit NETs formation
by: Xu Ying, et al.
Published: (2025)

Diastolic function alteration mechanisms in physiologic hypertrophy versus pathologic hypertrophy are elucidated by model-based Doppler E-wave analysis
by: Simeng Zhu, et al.
Published: (2014)

Gastroprotective mechanism of modified lvdou gancao decoction on ethanol-induced gastric lesions in mice: Involvement of Nrf-2/HO-1/NF-κB signaling pathway
by: Lei Xie, et al.
Published: (2022)

An Integration of Network Pharmacology and Experimental Verification to Investigate the Mechanism of Guizhi to Treat Nephrotic Syndrome
by: Dan He, et al.
Published: (2021)